RAR agonists stimulate SOX9 gene expression in breast cancer cell lines: Evidence for a role in retinoid-mediated growth inhibition

Oncogene

Volumn 21, Issue 51, 2002, Pages 7850-7860

  Afonja, Olubunmi ^a   Raaka, Bruce M ^a,c   Huang, Ambrose ^a   Das, Sharmistha ^a   Zhao, Xinyu ^a   Helmer, Elizabeth ^b   Juste, Dominique ^a   Samuels, Herbert H ^a,c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LONG ISLAND UNIVERSITY   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Breast cancer; Cell cycle; Growth inhibition; Retinoic acid receptor; Retinoids; SOX9

Indexed keywords

ESTRADIOL; HIGH MOBILITY GROUP PROTEIN; RETINOIC ACID RECEPTOR; RETINOID; THYROID HORMONE RECEPTOR; TRANSCRIPTION FACTOR;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CARBOXY TERMINAL SEQUENCE; CELL PROLIFERATION; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETIC REGULATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MOLECULAR CLONING; MULTIGENE FAMILY; PHASE TRANSITION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR GENE;

ANIMALS; BENZOATES; BREAST NEOPLASMS; CELL CYCLE; CELL DIVISION; ESTRADIOL; ESTROGENS; EXPRESSED SEQUENCE TAGS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE TARGETING; GENES, DOMINANT; GROWTH SUBSTANCES; HIGH MOBILITY GROUP PROTEINS; HUMANS; KIDNEY; MALE; MAMMARY GLANDS, ANIMAL; MICE; NEOPLASM PROTEINS; NEOPLASMS, HORMONE-DEPENDENT; ORGAN SPECIFICITY; RECEPTORS, ESTROGEN; RECEPTORS, RETINOIC ACID; RECOMBINANT FUSION PROTEINS; RETINOIDS; TESTIS; TETRAHYDRONAPHTHALENES; TRANSCRIPTION FACTORS; TRANSFECTION; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 18744374448     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1205985     Document Type: Article

References (75)

1. Agadir A, Cornic M, Gourmel B, Lefebvre P, Degos L and Chomienne C. (1994). Cell Mol. Biol. (Noisy-le-grand), 40, 263-274.
2. Amos B and Lotan R. (1990). Methods Enzymol., 190, 217-225.
3. Arafa HM, Elmazar MM, Hamada FM, Reichert U, Shroot B and Nau H. (2000). Arch. Toxicol., 73, 547-556.
4. Arafa HM, Hamada FM, Elmazar MM and Nau H. (1996). J. Chromatogr. A., 729, 125-136.
5. Bell DM, Leung KK, Wheatley SC, Ng LJ, Zhou S, Ling KW, Sham MH, Koopman P, Tam PP and Cheah KS. (1997). Nat. Genet., 16, 174-178.
6. Bi W, Deng JM, Zhang Z, Behringer RR and de Crombrugghe B. (1999). Nat. Genet., 22, 85-89.
7. Brand N, Petkovich M, Krust A, Chambon P, de The H, Marchio A, Tiollais P and Dejean A. (1988). Nature, 332, 850-853.
8. Brooks III SC, Kazmer S, Levin AA and Yen A. (1996). Blood, 87, 227-237.
9. Castaigne S, Chomienne C, Daniel MT, Ballerini P, Berger R, Fenaux P and Degos L. (1990). Blood, 76, 1704-1709.
10. Chomczynski P and Sacchi N. (1987). Anal. Biochem., 162, 156-159.
11. Dawson MI, Chao WR, Pine P, Jong L, Hobbs PD, Rudd CK, Quick TC, Niles RM, Zhang XK, Lombardo A, Ely KR, Shroot B and Fontana J. (1995). Cancer Res., 55, 4446-4451.
12. Desai SH, Boskovic G, Eastham L, Dawson M and Niles RM. (2000). Biochem. Pharmacol., 59, 1265-1275.
13. Diatchenko L, Lau YF, Campbell AP, Chenchik A, Moqadam F, Huang B, Lukyanov S, Lukyanov K, Gurskaya N, Sverdlov ED and Siebert PD. (1996). Proc. Natl. Acad. Sci. USA, 93, 6025-6030.
14. Easwaran V, Pishvaian M, Salimuddin and Byers S. (1999). Curr. Biol., 9, 1415-1418.
15. Fanjul AN, Bouterfa H, Dawson M and Pfahl M. (1996). Cancer Res., 56, 1571-1577.
16. Fenaux P. (1993). Acta Haematol., 89, 22-27.
17. Fitzgerald P, Teng M, Chandraratna RA, Heyman RA and Allegretto EA. (1997). Cancer Res., 57, 2642-2650.
18. Fontana JA, Miranda D and Mezu AB. (1990). Cancer Res., 50, 1977-1982.
19. Forman BM, Casanova J, Raaka BM, Ghysdael J and Samuels HH. (1992). Mol. Endocrinol., 6, 429-442.
20. Gianni M, Li Calzi M, Terao M, Guiso G, Caccia S, Barbui T, Rambaldi A and Garattini E. (1996). Blood, 87, 1520-1531.
21. Giese K, Kingsley C, Kirshner JR and Grosschedl R. (1995). Genes Dev., 9, 995-1008.
22. Giese K, Pagel J and Grosschedl R. (1997). Proc. Natl. Acad. Sci. USA, 94, 12845-12850.
23. Giguere V, Ong ES, Segui P and Evans RM. (1987). Nature, 330, 624-629.
24. Graham JD, Hunt SM, Tran N and Clarke CL. (1999). J. Mol. Endocrinol., 22, 295-304.
25. Graves JA. (1998). Bioessays, 20, 264-269.
26. Grunt TW, Dittrich E, Offterdinger M, Schneider SM, Dittrich C and Huber H. (1998). Br. J. Cancer, 78, 79-87.
27. Hanley NA, Hagan DM, Clement-Jones M, Ball SG, Strachan T, Salas-Cortes L, McElreavey K, Lindsay S, Robson S, Bullen P, Ostrer H and Wilson DI. (2000). Mech. Dev., 91, 403-407.
28. Hawkins JR. (1995). J. Endocrinol., 147, 183-187.
29. Healy C, Uwanogho D and Sharpe PT. (1999). Dev. Dyn., 215, 69-78.
30. Hong WK and Lippman SM. (1995). J. Natl. Cancer Inst. Monogr., 17, 49-53.
31. Hong WK and Sporn MB. (1997). Science, 278, 1073-1077.
32. Jinno H, Steiner MG, Mehta RG, Osborne MP and Telang NT. (1999). Carcinogenesis, 20, 229-236.
33. Kagechika H, Kawachi E, Hashimoto Y, Himi T and Shudo K. (1988). J. Med. Chem., 31, 2182-2192.
34. Kent J, Wheatley SC, Andrews JE, Sinclair AH and Koopman P. (1996). Development, 122, 2813-2822.
35. Koopman P. (1999). Cell. Mol. Life Sci., 55, 839-856.
36. Koopman P. (2001). Exs., 91, 25-56.
37. Krust A, Kastner P, Petkovich M, Zelent A and Chambon P. (1989). Proc. Natl. Acad. Sci. USA, 86, 5310-5314.
38. Lacroix A and Lippman ME. (1980). J. Clin. Invest., 65, 586-591.
39. Langenfeld J, Lonardo F, Kiyokawa H, Passalaris T, Ahn MJ, Rusch V and Dmitrovsky E. (1996). Oncogene, 13, 1983-1990.
40. Lefebvre V and de Crombrugghe B. (1998). Matrix Biol., 16, 529-540.
41. Lefebvre V, Huang W, Harley VR, Goodfellow PN and de Crombrugghe B. (1997). Mol. Cell. Biol., 17, 2336-2346.
42. Lefebvre V, Li P and de Crombrugghe B. (1998). EMBO J., 17, 5718-5733.
43. Lotan R. (1980). Biochim. Biophys. Acta, 605, 33-91.
44. Mangelsdorf DJ. (1994). Nutr. Rev., 52, S32-S44.
45. Mangelsdorf DJ, Kliewer SA, Kakizuka A, Umesono K and Evans RM. (1993). Recent Prog. Horm. Res., 48, 99-121.
46. Mangelsdorf DJ, Ong ES, Dyck JA and Evans RM. (1990). Nature, 345, 224-229.
47. Mangiarotti R, Danova M, Alberici R and Pellicciari C. (1998). Br. J. Cancer, 77, 186-191.
48. Marth C, Mayer I and Daxenbichler G. (1984). Biochem. Pharmacol., 33, 2217-2221.
49. Nagai K. (2001). Gene, 270, 161-169.
50. Offterdinger M, Schneider SM, Huber H and Grunt TW. (1998). Biochem. Biophys. Res. Commun., 251, 907-913.
51. Olney PN, Kean LS, Graham D, Elsas LJ and May KM. (1999). Am. J. Med. Genet., 84, 20-24.
52. Panda DK, Miao D, Lefebvre V, Hendy GN and Goltzman D. (2001). J. Biol. Chem., 276, 41229-41236.
53. Raffo P, Emionite L, Colucci L, Belmondo F, Moro MG, Bollag W and Toma S. (2000). Anticancer Res., 20, 1535-1543.
54. Schafer AJ, Foster JW, Kwok C, Weller PA, Guioli S and Goodfellow PN. (1996). Ann. NY Acad. Sci., 785, 137-149.
55. Seewaldt VL, Johnson BS, Parker MB, Collins SJ and Swisshelm K. (1995). Cell Growth Differ., 6, 1077-1088.
56. Seewaldt VL, Caldwell LE, Johnson BS, Swisshelm K, Collins SJ and Tsai S. (1997a). Exp. Cell Res., 236, 16-28.
57. Seewaldt VL, Dietze EC, Johnson BS, Collins SJ and Parker MB. (1999). Cell Growth Differ., 10, 49-59.
58. Seewaldt VL, Kim JH, Caldwell LE, Johnson BS, Swisshelm K and Collins SJ. (1997b). Cell Growth Differ 8, 631-641.
59. Sekiya I, Koopman P, Tsuji K, Mertin S, Harley V, Yamada Y, Shinomiya K, Niguji A and Noda M. (2001). J. Cell Biochem., 81 (Suppl): 71-78.
60. Sekiya I, Tsuji K, Koopman P, Watanabe H, Yamada Y, Shinomiya K, Nifuji A and Noda M. (2000). J. Biol. Chem., 275, 10738-10744.
61. Shao ZM, Dawson MI, Li XS, Rishi AK, Sheikh MS, Han QX, Ordonez JV, Shroot B and Fontana JA. (1995). Oncogene, 11, 493-504.
62. Sheikh MS, Rochefort H and Garcia M. (1995) Oncogene, 11, 1899-1905.
63. Sheikh MS, Shao ZM, Chen JC, Hussain A, Jetten AM and Fontana JA. (1993). J. Cell Biochem., 53, 394-404.
64. Sheikh MS, Shao ZM, Li XS, Dawson M, Jetten AM, Wu S, Conley BA, Garcia M, Rochefort H and Fontana JA. (1994). J. Biol. Chem., 269, 21440-21447.
65. Schneider SM, Offterdinger M, Huber H and Grunt TW. (2000). Cancer Res., 60, 5479-5487.
66. Smith MA, Parkinson DR, Cheson BD and Friedman MA. (1992). J. Clin. Oncol., 10, 839-864.
67. Sporn MB and Roberts AB. (1983). Cancer Res 43, 3034-3040.
68. Sudbeck P and Scherer G. (1997). J. Biol. Chem., 272, 27848-27852.
69. Teixeira C and Pratt MA. (1997). Mol. Endocrinol., 11, 1191-1202.
70. Toma S, Isnardi L, Raffo P, Dastoli G, De Francisci E, Riccardi L, Palumbo R and Bollag W. (1997). Int. J. Cancer, 70, 619-627.
71. van der Burg B, van der Leede BM, Kwakkenbos-Isbrucker L, Salverda S, de Laat SW and van der Saag PT. (1993). Mol. Cell Endocrinol., 91, 149-157.
72. van der Leede BJ, Folkers GE, van den Brink CE, van der Saag PT and van der Burg B. (1995). Mol. Cell Endocrinol., 109, 77-86.
73. Watanabe K, Clarke TR, Lane AH, Wang X and Donahoe PK. (2000). Proc. Natl. Acad. Sci. USA, 97, 1624-1629.
74. Willhite CC, Dawson MI and Reichert U. (1996). Drug Metab. Rev., 28, 105-119.
75. Zhou Q, Stetler-Stevenson M and Steeg PS. (1997). Oncogene, 15, 107-115.